Live Breaking News & Updates on Lutzb giebel

Stay informed with the latest breaking news from Lutzb giebel on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Lutzb giebel and stay connected to the pulse of your community

SpyBiotech Appoints Seasoned Biotech Executive Mark Leuchtenberger as Chief Executive Officer

Novel Vaccine Company Expands Leadership Team and Establishes US Presence SpyBiotech, a British biotechnology company with a novel vaccine platform technology that can target infectious diseases,

Cambridge , Cambridgeshire , United-kingdom , United-states , Massachusetts , America , British , Lutzb-giebel , Kostenloser-wertpapierhandel , Brooklyn-immunotherapeutics , Aleta-biotherapeutics , Michael-falcone

SpyBiotech raises $32.5M in Series A funding and appoints Lutz B. Giebel as Chairman to support ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
SpyBiotech raises $32.5M in Series A funding and appoints Lutz B. Giebel as Chairman to support ...
SpyBiotechFebruary 10, 2021 GMT
SpyBiotech has raised $32.5M from leading investors to advance development of its novel “plug and display” vaccine platform technology
Braavos Investment Advisers led the round, joined by new investor Oxford Investment Consultants; founding investors Oxford Sciences Innovation and GV also participated
Lutz B. Giebel joins as Chairman, strengthening governance as company expands clinical development and builds operational resource
ADVERTISEMENT
OXFORD, United Kingdom, Feb. 10, 2021 (GLOBE NEWSWIRE) -- SpyBiotech, a British biotechnology company with a novel vaccine platform technology targeting infectious diseases, cancer and chronic diseases, today announces it has raised $32.5 million in Series A equity financing and appointed Lutz B. Giebel as Chairman.

India , United-kingdom , San-francisco , California , United-states , British , Jane-smit , Sarah-macleod , Spycatcher-spytag , Lutzb-giebel , Jessica-hodgson , Hbsag-vlps

SpyBiotech raises $32.5M in Series A funding and appoints Lutz B. Giebel as Chairman to support its novel vaccine platform through accelerated clinical development

(1)
SpyBiotech has raised $32.5M from leading investors to advance development of its novel "plug and display" vaccine platform technology
Braavos Investment Advisers led the round, joined by new investor Oxford Investment Consultants; founding investors Oxford Sciences Innovation and GV also participated
Lutz B. Giebel joins as Chairman, strengthening governance as company expands clinical development and builds operational resource
OXFORD, United Kingdom, Feb. 10, 2021 (GLOBE NEWSWIRE) -- SpyBiotech, a British biotechnology company with a novel vaccine platform technology targeting infectious diseases, cancer and chronic diseases, today announces it has raised $32.5 million in Series A equity financing and appointed Lutz B. Giebel as Chairman.

India , United-kingdom , San-francisco , California , United-states , British , Jane-smit , Sarah-macleod , Spycatcher-spytag , Lutzb-giebel , Kostenloser-wertpapierhandel , Jessica-hodgson

Investegate |SpyBiotech Announcements | SpyBiotech: SpyBiotech raises $32.5M in Series A funding and appoints Lutz B. Giebel as Chairman to support its novel vaccine platform through accelerated clinical development

Investegate announcements from SpyBiotech, SpyBiotech raises $32.5M in Series A funding and appoints Lutz B. Giebel as Chairman to support its novel vaccine platform through accelerated clinical development

India , United-kingdom , San-francisco , California , United-states , British , Jane-smit , Sarah-macleod , Spycatcher-spytag , Lutzb-giebel , Jessica-hodgson , Hbsag-vlps

Notch Soars Out of the Gate with $85 Million; Two More Follow Closely Behind

There have been a few life sciences companies that have been attracting attention this week with strong Series A rounds.

Beijing , China , United-kingdom , Toronto , Ontario , Canada , Sunnybrook , Alberta , British , Lutzb-giebel , Peter-zandstra , Andre-crawford